PricewaterhouseCoopers
Global

Click the 'X' in the top right corner to close this window.
  • Home
  • Industry sectors
    • All industries
    • Forest, paper & packaging
    • Aerospace & defence
    • Government/public services
    • Asset management
    • Healthcare
    • Automotive
    • Hospitality & leisure
    • Banking & capital markets
    • Industrial manufacturing
    • Chemicals
    • Insurance
    • Communications
    • Metals
    • Energy, utilities & mining
    • Pharmaceuticals & life sciences
    • Engineering & construction
    • Retail & consumer
    • Entertainment & media
    • Technology
    • Financial services
    • Transportation & logistics
  • Today's challenges
    • All challenges
    • Operating globally
    • Convergence
    • Reducing costs
    • Making smarter risk decisions
    • Reporting performance

    • Managing people
    • Strengthening governance and regulatory compliance
    • Managing through the downturn
  • Our services
    • All services
    • Audit and assurance
    • Consulting
    • Deals
    • Human resources
    • Tax
  • About us
    • Corporate governance
    • Corporate responsibility
    • Global Annual Review
    • Offices worldwide
    • Women at PwC
  • Research & insights
  • Careers
  • Press room

Press room

27 July 2009
Growth In Personalised Medicine to Drive Alliances Between Diagnostic and Pharmaceutical Industries

30 April 2009
Challenging times require bold moves if pharma companies are to survive the immediate storm

25 February 2009
Smaller, refocused salesforce will enable pharma companies to create greater value for patients

29 January 2009
Biomedical industry becomes increasingly vital to state’s economic stability, finds California Healthcare Institute and PricewaterhouseCoopers

23 December 2008
PricewaterhouseCoopers applauds new medical device code of ethics that eliminates all gifts for doctors and lays foundation for rebuilding trust in the industry

17 September 2008
Growth and discovery are eclipsing cost in a rapidly changing Asia pharma industry, finds PricewaterhouseCoopers report

20 June 2008
Pharma 2020: companies will use virtual R&D to increase innovation and reduce commercial deficit

12 June 2008
New report on Massachusetts Life Sciences Super Cluster finds region is strong, but can’t rest on its laurels

7 August 2007
Asia Pacific to replace United States and Europe as pharmaceutical industry powerhouse, finds PricewaterhouseCoopers

  • Pharmaceuticals and life sciences
  • Services
  • Case studies
  • Publications
  • Pharma 2020 series
  • Press room
  • Events
  • Contacts
  • Health industries

Contacts
Global
Simon Friend - profile
Pharmaceuticals and life sciences leader
Tel: +44 (20) 7213 4875
Mike Swanick - profile
Pharmaceuticals and life sciences tax leader
Tel: +1 (267) 330 6060
Dr. Steve Arlington - profile
Pharmaceuticals and life sciences advisory leader
Tel: +44 (20) 7804 3997
Pharma 2020 series
  • Offices worldwide
  • Site map
  • RSS
  • PwC portal
  • Contact us
International PwC Sites
© 2002-2009 PricewaterhouseCoopers. All rights reserved.
PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.
  • Privacy
  • Legal
  • About site provider